# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-007688
Filing Date
2021-01-26
Accepted
2021-01-26 16:49:34
Documents
7
Period of Report
2021-02-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm213282-2_def14a.htm | DEF 14A | 1407642
2 | GRAPHIC | lg_essa-4c.jpg | GRAPHIC | 21245
3 | GRAPHIC | lg_laurelhilladvgrp-4c.jpg | GRAPHIC | 42515
4 | GRAPHIC | tm213282d1-guide1_essa4clr.jpg | GRAPHIC | 772977
5 | GRAPHIC | tm213282d1-guide2_essa4clr.jpg | GRAPHIC | 576098
6 | GRAPHIC | tm213282d1-proxy1_essa4c.jpg | GRAPHIC | 755514
7 | GRAPHIC | tm213282d1-proxy2_essabw.jpg | GRAPHIC | 780335
| Complete submission text file | 0001104659-21-007688.txt |  | 5469759

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37410 | Film No.: 21554740
SIC: 2834 Pharmaceutical Preparations